To include your compound in the COVID-19 Resource Center, submit it here.

Allergan among companies unveiling price hikes

Allergan plc (NYSE:AGN) raised the price of 18 drugs by 9.5%, just under the company's pledge to limit yearly price increases to single digits, according to a Jefferies report.

Allergan spokesperson Mark Marmur told BioCentury the company increased its average list price of drugs for 2018 by 7.3% and expects a net increase of about 2-3% after

Read the full 562 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE